Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...
WASHINGTON, D.C. – Whether insurers cover weight loss drugs like Ozempic is a unique risk proposition that needs more data. According to research earlier this year from Morningstar DBRS, health and ...
Collectively, these factors are expected to meaningfully propel interest in categories across sports nutrition, vitamins and dietary supplements and even OTC drugs, though the depth and persistence of ...
Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...